by Collagen meniscus implants are medical devices used for regeneration of injured meniscus tissues during knee surgery. These biodegradable implants help in cushioning and shock absorption of knees and aid faster recovery from injuries.
The global Collagen Meniscus Implant Market is estimated to be valued at US$ 25 million in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increasing cases of knee injuries among older population due to age-related wear and tear coupled with rising sports injuries is a major factor driving demand for collagen meniscus implants. Ageing population across developed nations are more prone to degenerative disorders leading to partial or total tears in meniscus cartilage. This requires surgical intervention through implantation of collagen scaffolds that facilitate natural tissue regeneration. The global geriatric population is expected to double by 2050 and rise in joint disorders due to ageing will continue to propel the collagen meniscus implant market during the forecast period.
SWOT Analysis
Strength: Collagen meniscus implants provide a replacement for damaged meniscus tissue without removing the entire meniscus. They help distribute loads across the knee joint and act as shock absorbers.
Weakness: Long term outcomes and durability of collagen meniscus implants is still unclear. There are concerns regarding resorption and loosening over time.
Opportunity: Growing geriatric population and increasing rates of osteoarthritis and sports injuries will drive the demand for meniscus replacement options. Minimal invasive surgical techniques expand the addressable patient population.
Threats: Alternative treatment options like meniscus transplantation and repair present competition. Strict regulatory approvals and reimbursement policies can impact market uptake.
Key Takeaways
Global Collagen Meniscus Implant Market Size is expected to witness high growth over the forecast period of 2024 to 2031.
North America region currently dominates the market and is expected to maintain its leading position during the forecast period. This can be attributed to growing prevalence of knee injuries, rising healthcare expenditure, availability of advanced surgical procedures and supportive reimbursement structure in the region.
Key players operating in the Collagen Meniscus Implant market are Stryker Corporation, RTI Surgical, Orthonika, Zimmer Biomet, Merete GmbH, and LARS Laboratories. Stryker Corporation holds the leading market share owing to its broad portfolio of meniscal implants and repair products. The company is focused on developing next generation implants with enhanced durability and fixation capabilities.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
